Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

INMD

Inmode Ltd

Feb 12 • 03:47PM ET

14.34

+0.10 0.67 %

Healthcare • Medical Devices • Israel • NASD

Peers: ALGN IRTC CUTR PODD NVCR HAE CERS VCEL MDXG CLGN

| Held by: IEFA SCZ IXUS IZRL AVDV EIS IDEV SPDW SEIS GWX

Scroll to Statements

Index	-	P/E	9.91	EPS (ttm)	1.45	Insider Own	10.65%	Shs Outstand	63.36M	Perf Week	-3.27%
Market Cap	908.31M	Forward P/E	9.33	EPS next Y	1.54	Insider Trans	0.00%	Shs Float	56.48M	Perf Month	2.18%
Enterprise Value	361.21M	PEG	-	EPS next Q	0.30	Inst Own	59.11%	Short Float	5.85%	Perf Quarter	-1.20%
Income	93.83M	P/S	2.45	EPS this Y	-9.61%	Inst Trans	-	Short Ratio	3.80	Perf Half Y	-2.14%
Sales	370.50M	P/B	1.33	EPS next Y	6.27%	ROA	12.09%	Short Interest	3.30M	Perf YTD	-2.41%
Book/sh	10.78	P/C	1.64	EPS next 5Y	-1.70%	ROE	13.53%	52W High	19.78 -27.52%	Perf Year	-24.11%
Cash/sh	8.76	P/FCF	10.16	EPS past 3/5Y	-9.87% 6.62%	ROIC	13.63%	52W Low	13.14 9.10%	Perf 3Y	-58.59%
Dividend Est.	-	EV/EBITDA	4.20	Sales past 3/5Y	-6.57% 12.44%	Gross Margin	78.54%	Volatility	3.50% 3.26%	Perf 5Y	-57.82%
Dividend TTM	-	EV/Sales	0.97	EPS Y/Y TTM	-38.62%	Oper. Margin	23.05%	ATR (14)	0.55	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.61	Sales Y/Y TTM	-6.16%	Profit Margin	25.33%	RSI (14)	44.53	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.88	EPS Q/Q	-62.92%	SMA20	-3.54%	Beta	2.18	Target Price	16.80
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	6.13%	SMA50	-2.28%	Rel Volume	0.89	Prev Close	14.24
Employees	660	LT Debt/Eq	0.01	Earnings	Feb 10 BMO	SMA200	-1.86%	Avg Volume	870.14K	Price	14.34
IPO	Aug 08, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.36% 2.10%	Trades		Volume	750,713	Change	0.67%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-25	Downgrade	BTIG Research	Buy → Neutral
Apr-28-25	Downgrade	Robert W. Baird	Outperform → Neutral	$22 → $16
Oct-17-24	Initiated	BTIG Research	Buy	$25
Jul-23-24	Downgrade	Jefferies	Buy → Hold	$21 → $19
Nov-03-23	Downgrade	UBS	Buy → Neutral	$52 → $24
Oct-13-23	Downgrade	Canaccord Genuity	Buy → Hold	$55 → $22
Mar-29-23	Initiated	UBS	Buy	$40
Feb-17-23	Downgrade	Needham	Buy → Hold
Dec-21-22	Initiated	Barclays	Overweight	$44
Oct-12-22	Initiated	Jefferies	Buy	$40
May-25-21	Initiated	Barclays	Overweight	$92
May-18-21	Initiated	Needham	Buy	$94
Sep-03-19	Initiated	UBS	Buy	$28
Sep-03-19	Initiated	Robert W. Baird	Outperform	$27
Sep-03-19	Initiated	Canaccord Genuity	Buy	$30
Sep-03-19	Initiated	Barclays	Overweight	$27

Show Previous Ratings

Feb-10-26 04:32PM	InMode Ltd. Q4 2025 Earnings Call Summary (Moby)
04:02PM	InMode Ltd (INMD) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... (GuruFocus.com)
03:50PM	InMode Q4 Earnings Call Highlights (MarketBeat)
07:23AM	InMode: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million (PR Newswire)
08:00AM	Loading…
Feb-03-26 08:00AM	InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference (PR Newswire)
Feb-02-26 07:00AM	InMode Responds to Transaction Rumors (PR Newswire) +5.79%
Jan-30-26 04:53PM	Deal Dispatch: Musk Merger Talk, LIV Golf Stakes, And A Flurry Of M&A From AI To Athleisure (Benzinga)
Jan-29-26 12:44PM	Steel Partners Targets InMode, Citing Stock Underperformance (Benzinga) +5.95%
Jan-28-26 05:30PM	Steel Partners Holdings L.P. Announces It Has Presented $18.00 Per Share Offer for 51% of InMode Ltd. to Board of Directors (Business Wire)
Jan-26-26 03:34PM	InMode Flies To Three-Month High On A Rumored $1.1 Billion Takeover Offer (Investor's Business Daily) +10.61%
Jan-08-26 07:00AM	InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M (PR Newswire) -8.82%
Nov-07-25 04:00AM	InMode Ltd (INMD) Q3 2025 Earnings Call Highlights: Global Expansion and Revenue Growth Amid ... (GuruFocus.com)
Nov-05-25 07:14AM	InMode: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins (PR Newswire)
08:08AM	Loading…
Nov-04-25 08:08AM	What To Expect From InMode Ltd (INMD) Q3 2025 Earnings (GuruFocus.com)
Nov-03-25 08:05AM	InMode Appoints Michael Dennison as President of North America (PR Newswire)
Oct-30-25 08:30AM	InMode to Participate in Upcoming Investor Conferences (PR Newswire)
Oct-09-25 07:00AM	InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M (PR Newswire) +5.58%
Oct-07-25 05:39AM	Sanuwave Health (SNWV) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Sep-09-25 08:15AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders (PR Newswire)
Sep-03-25 11:34AM	Do Options Traders Know Something About InMode Stock We Don't? (Zacks)
Sep-02-25 08:30AM	InMode to Present at Baird 2025 Global Healthcare Conference (PR Newswire)
Aug-05-25 08:30AM	InMode to Participate in Upcoming Investor Conferences (PR Newswire)
Jul-30-25 08:10AM	InMode (INMD) Q2 Earnings and Revenues Beat Estimates (Zacks)
07:08AM	InMode: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins (PR Newswire)
Jul-29-25 09:51AM	What To Expect From InMode Ltd (INMD) Q2 2025 Earnings (GuruFocus.com)
Jul-25-25 10:31AM	Are Options Traders Betting on a Big Move in InMode Stock? (Zacks)
Jul-24-25 10:00AM	Envista (NVST) Earnings Expected to Grow: Should You Buy? (Zacks)
10:00AM	Loading…
Jul-23-25 10:00AM	InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-16-25 09:39AM	Canaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD) (Insider Monkey)
Jul-10-25 07:00AM	InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M (PR Newswire)
May-28-25 08:30AM	InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 (PR Newswire)
May-23-25 10:26AM	Do Options Traders Know Something About InMode Stock We Don't? (Zacks)
May-20-25 09:19AM	InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology (PR Newswire)
May-09-25 08:22AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program (PR Newswire)
May-07-25 08:30AM	InMode to Present at Upcoming Investor Conferences and Events (PR Newswire)
May-06-25 08:03AM	InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges (PR Newswire)
Apr-29-25 07:00AM	InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade) (Seeking Alpha)
05:57AM	Company News for Apr 29, 2025 (Zacks)
03:02AM	InMode Ltd (INMD) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
01:52AM	InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade) (Seeking Alpha)
Apr-28-25 11:53AM	InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript (Seeking Alpha) -12.08%
08:25AM	InMode (INMD) Lags Q1 Earnings Estimates (Zacks)
07:25AM	InMode: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease (PR Newswire)
Apr-24-25 10:01AM	Earnings Preview: Envista (NVST) Q1 Earnings Expected to Decline (Zacks)
Apr-21-25 10:00AM	Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline (Zacks)
Apr-14-25 07:00AM	InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M (PR Newswire)
Apr-10-25 11:36AM	InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock? (Zacks) -8.80%
Apr-03-25 04:26AM	InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade) (Seeking Alpha) -9.34%
Mar-27-25 05:00AM	HCI Group and Boise Cascade have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Mar-26-25 11:44AM	3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally (Zacks)
08:30AM	InMode to Present at the 24th Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-25-25 09:40AM	Is InMode (INMD) Stock Undervalued Right Now? (Zacks)
Mar-06-25 07:30AM	InMode Responds to Doma Perpetual's Letters (PR Newswire)
Mar-03-25 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire)
Feb-06-25 06:00PM	InMode (INMD) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-05-25 07:10AM	InMode Ltd (INMD) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
02:08AM	InMode Ltd (INMD) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... (GuruFocus.com)
Feb-04-25 07:16AM	InMode: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program (PR Newswire)
Feb-03-25 08:30AM	InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference (PR Newswire)
Jan-29-25 09:48AM	Do Options Traders Know Something About InMode (INMD) Stock We Don't? (Zacks)
Jan-16-25 07:00AM	InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced (PR Newswire)
Jan-15-25 08:05AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback (PR Newswire)
Jan-08-25 07:00AM	InMode to Report Fourth Quarter and Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M (PR Newswire) -7.99%
07:00AM	InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M (PR Newswire)
Dec-10-24 10:53PM	Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey)
Nov-06-24 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire) +7.65%
Oct-31-24 07:29AM	InMode Sees Revenue Growth Amidst Challenges in Q3 2024 (TipRanks)
03:07AM	InMode Ltd (INMD) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
01:25AM	Q3 2024 Inmode Ltd Earnings Call (Thomson Reuters StreetEvents)
Oct-30-24 03:45PM	InMode (INMD) Q3 2024 Earnings Call Transcript (Motley Fool)
08:10AM	InMode (INMD) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:07AM	InMode: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024) (PR Newswire)
Oct-29-24 09:11AM	What To Expect From InMode Ltd (INMD) Q3 2024 Earnings (GuruFocus.com)
Oct-24-24 07:03AM	InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories (PR Newswire)
Oct-23-24 10:01AM	Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline (Zacks)
Oct-14-24 09:40AM	Is InMode (INMD) a Great Value Stock Right Now? (Zacks)
Oct-13-24 05:25PM	InMode price target lowered to $27 from $29 at Barclays (TipRanks)
Oct-10-24 07:00AM	InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 (PR Newswire) +7.38%
Oct-09-24 03:42PM	InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations (GuruFocus.com)
Oct-02-24 07:28AM	InMode Restructures Amidst Global Expansion (TipRanks)
Oct-01-24 07:00AM	InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy (PR Newswire) -8.55%
Sep-26-24 09:40AM	Should Value Investors Buy InMode (INMD) Stock? (Zacks)
Sep-23-24 05:34AM	InMode (INMD): Among the Worst Middle East and Africa Stocks to Buy Now (Insider Monkey) -5.80%
Sep-10-24 09:40AM	Are Investors Undervaluing InMode (INMD) Right Now? (Zacks) +8.83%
07:00AM	InMode Announces Share Repurchase Program of Up to 7.68 Million Shares (PR Newswire)
Sep-04-24 08:30AM	InMode to Present at 2024 Baird Global Healthcare Conference (PR Newswire)
Sep-01-24 11:27PM	InMode (INMD): The Best Middle East and Africa Stocks to Buy According to Analysts? (Insider Monkey)
Aug-14-24 11:05AM	InMode Ltd. (INMD): Challenges and Insights in the Beauty Industry (Insider Monkey)
Aug-09-24 06:46AM	Why Are Analysts Bullish on InMode Ltd. (INMD) Right Now? (Insider Monkey)
Aug-06-24 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire)
Aug-01-24 10:30PM	InMode (INMD) Q2 2024 Earnings Call Transcript (Motley Fool) -8.55%
08:15AM	InMode (INMD) Q2 Earnings and Revenues Top Estimates (Zacks)
07:14AM	InMode: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M (PR Newswire)

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INMD

Inmode Ltd

Upgrade your FINVIZ experience